GILEAD SCIENCES, INC. — Director's Dealing 2017

Sep 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-09-07

Reporting Person: Washington Robin L (EVP, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-07	Common Stock	M	33750	$24.295	Acquired	43352	Direct
2017-09-07	Common Stock	S	33750	$85.00	Disposed	9602	Direct
2017-09-07	Common Stock	S	18070	$85.00	Disposed	103477	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-07	Non-qualified Stock Option (Right to Buy)	$24.295	M	33750	Disposed	2022-01-26	Common Stock (33750)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.